BRÈVE

sur TERACT (EPA:TRACT)

TERACT Reports Revenue Decline in H1 2025-2026 Amid Strategic Shifts

Graphique de l'évolution du cours de l'action TERACT (EPA:TRACT).

TERACT's revenue for H1 2025-2026 is reported at €361.9 million, a decrease of 7.1% on a reported basis and 3.3% like-for-like compared to the same period the previous year. The drop is linked to the franchising of stores against a sluggish economic backdrop. The Garden Centre/Pet Retail sector saw a revenue fall to €294.2 million, primarily due to the franchising of 38 Gamm vert stores. In Food Retail, revenue declined to €67.6 million, influenced by the sale of Bio&Co completed in October 2025.

Additionally, InVivo Group, in concert with TERACT's founders, has filed for a public buy-out followed by a squeeze-out of TERACT shares. This move aims to streamline strategic direction and stabilize the shareholder base. Despite the decline in revenue, TERACT continues to advance its own brand strategy and expand its e-commerce presence.

R. E.

Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de TERACT